RDRoland Dahlem

Roland Dahlem

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Roland Dahlem has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Multicenter Analysis of Long-Term Outcomes of Artificial Urinary Sphincter Surgery After Urethroplasty

    by Meghan F. Davis, Dmitriy Nikolavsky, Andre G. Cavalcanti, Brian J. Flynn, Reynaldo G. Gomez, Jeff Loh-Doyle, Stuart D. Boyd, Akio Horiguchi, Matthias D. Hofer, Margit Fisch, et al.

    The artificial urinary sphincter (AUS) is the gold standard for male stress urinary incontinence (SUI). There is limited and conflicting evidence examining outcomes in AUS insertion after urethroplasty particularly whether and how urethroplasty techniques affect them. We evaluated complications of AUS insertion after urethroplasty in a multi-institutional cohort. We hypothesize that complications occur at higher rates and vary between transecting and non-transecting urethroplasty. We retrospectively reviewed patients who underwent AUS after urethroplasty at 15 institutions. Demographic and clinical variables were analyzed. Urethroplasties were categorized as transecting or non-transecting. Long-term complications included AUS infection, erosion, and mechanical failure. 178 cases were identified performed by 17 surgeons (range 4-40) from 15 institutions with median follow-up of 33.5 (IQR 46) months). AUS complications requiring explantation, including infection, erosion and mechanical failure following transecting urethroplasty occurred in 56.2% compared to 23.5% following non-transecting urethroplasty (p < 0.001). Transecting urethroplasty technique was correlated with increased risk of device explant both from erosion (p=0.004) and atrophy (p=0.008). Radiation (HR 0.46, 95% CI 0.28-0.76, p=0.002), hypertension (HR 0.44, 95% CI 0.27-0.73, p=0.0008) and patient age (>68) (HR 0.5, 95% CI 0.3-0.81, p=0.004) also correlated to risk of device explantation. Risk of experiencing AUS complications is higher in patient with transecting urethroplasty compared to the non-transecting group. Non-transecting urethroplasty may be advisable if a subsequent need for AUS is anticipated.


  • Harnröhrenstrikturen

    by C. Philip Reiß, Roland Dahlem

  • Komplexe Fisteln der hinteren Harnröhre

    by Luis Alex Kluth, Roland Dahlem

  • Harnröhrenstrikturen

    by C. Philip Reiß, Roland Dahlem

  • Assessing the Outcome of Holmium Laser Enucleation of the Prostate by Age, Prostate Volume, and a History of Blood Thinning Agents: Report from a Single-Center Series of >1800 Consecutive Cases

    by Philipp Gild, Lukas Lenke, Raisa Sinaida Pompe, Malte Wolfram Vetterlein, Tim Alexander Ludwig, Armin Soave, Felix K.-H. Chun, Sascha Ahyai, Roland Dahlem, Margit Fisch, et al.

    Purpose: To assess perioperative outcomes of HoLEP in a real-world scenario and with a focus on demanding patient factors such as large prostate size, advanced patient age, and anticoagulation therapy (AT). Material & Methods: We retrospectively analysed HoLEP procedures at our institution between 2010-2016. After stratification by prostate volume, age, and AT, perioperative and early voiding characteristics were compared. A multivariable regression model was employed to identify predictors of prolonged time of catheterization (defined as being above groups median). Results: The study cohort consisted of 1,816 men with a median age of 71 years (IQR:66-76), a median prostate volume of 80 ml (IQR:58-105) and American Society of Anesthesiologists (ASA) score ≥3 in 618 men (34%). Median time of enucleation and morcellation were 43 min (IQR:31-60) and 10 min (IQR:6-18), respectively. Perioperative blood transfusions were administered in 44 (2.4%) cases, severe postoperative complications (Clavien-Dindo grade ≥3b) occured in 61 (3.3%) of cases. The median time of catheterization was 2 days (IQR: 2-2), with prolonged catheterization occuring in 277 (15%) of cases. After adjustment, very large prostates (4th volume quartile (106-280ml) (OR:1.8, 95%CI:1.3-2.6, p=0.001), therapeutic low-molecular-weight heparin bridging regimen (OR: 2.2, 95%CI:1.4-3.6, p=0.037), low-dose acetylsalicyclic acid (OR:1.5, 95%CI:1.0-2.2, p=0.015), and a history of direct oral anticoagulation (OR:2.3, 95%CI:1.2-4.0, p=0.022), but not patient age, were independently associated with prolonged catherization. Conclusions: We confirm HoLEP as safe and efficient; however, patients with very large prostates and patients with a history of anticoagulation therapy are at risk of prolonged catheterization.


  • Open Access

    The Impact of Circulating Tumor Cells on Venous Thromboembolism and Cardiovascular Events in Bladder Cancer Patients Treated with Radical Cystectomy

    by Michael Rink, Sabine Riethdorf, Hang Yu, Mara Kölker, Malte W. Vetterlein, Roland Dahlem, Margit Fisch, Klaus Pantel, Armin Soave

    Background: Cancer is a relevant risk factor for venous thromboembolism (VTE). Circulating tumor cells (CTC) are associated with an increased risk of VTE in breast cancer. In addition, circulating cell-free nucleic acids have been associated with cardiovascular events (CVE). Objective: To investigate the association of CTC status and the risk of VTE as well as CVE in urothelial carcinoma of the bladder (UCB) patients treated with radical cystectomy (RC). Methods: We collected data of 189 UCB patients treated with RC at our institution. Blood samples were acquired preoperatively and analyzed for CTC using the CellSearch® system. Thirty-day postoperative complications were extracted from digital charts and graded according to the Clavien–Dindo classification (CDC). Moreover, each patient’s individual Comprehensive Complication Index® (CCI®) was calculated. Results: CTC were present in 43 patients (22.8%). Overall, six patients experienced VTE (3.2%) and eight patients (4.2%) experienced CVE. There was no association of VTE or CVE according to CTC status. In total, 168 patients (89%) experienced a total of 801 complications, of which the majority was classified as “minor” (CDC grade ≤ IIIa; 79%). There was no association between CTC status and any grade of a complication or CCI®. Presence of CTC was associated with more aggressive clinicopathological UCB features. Conclusions: The overall rate of VTE and CVE was low in our study. Presence of CTC was neither associated with an increased risk of VTE nor CVE in UCB patients treated with RC. According to this study, CTC are not a qualified biomarker for individualized thromboprophylaxis management in these patients.


  • Open Access

    Do Younger Patients with Muscle-Invasive Bladder Cancer have Better Outcomes?

    by Florian Janisch, Hang Yu, Malte W. Vetterlein, Roland Dahlem, Oliver Engel, Margit Fisch, Shahrokh F. Shariat, Armin Soave, Michael Rink

    Urothelial cancer of the bladder (UCB) is usually a disease of the elderly. The influence of age on oncological outcomes remains controversial. This study aims to investigate the impact of age on UCB outcomes in Europe focusing particularly on young and very young patients. We collected data of 669 UCB patients treated with RC at our tertiary care center. We used various categorical stratifications as well as continuous age to investigate the association of age and tumor biology as well as endpoints with descriptive statistics and Cox regression. The median age was 67 years and the mean follow-up was 52 months. Eight patients (1.2%) were ≤40 years old and 39 patients (5.8%) were aged 41–50 years, respectively. In multivariable analysis, higher continuous age and age above the median were independent predictors for disease recurrence, and cancer-specific and overall mortality (all p-values ≤ 0.018). In addition, patients with age in the oldest tertile group had inferior cancer-specific and overall survival rates compared to their younger counterparts. Young (40–50 years) and very young (≤40 years) patients had reduced hazards for all endpoints, which, however, were not statistically significant. Age remains an independent determinant for survival after RC. Young adults did, however, not have superior outcomes in our analyses. Quality of life and complications are endpoints that need further evaluation in patients undergoing RC.


  • Open Access

    Negative Self-Perception and Self-Attitude of Sexuality Is a Risk Factor for Patient Dissatisfaction Following Penile Surgery with Small Intestinal Submucosa Grafting for the Treatment of Severe Peyronie’s Disease

    by Armin Soave, Sebastian Laurich, Roland Dahlem, Malte W. Vetterlein, Oliver Engel, Timo O. Nieder, Peer Briken, Michael Rink, Margit Fisch, Philip Reiss

    Objective: To assess patient satisfaction with surgical outcome, body related self-perceptions, self-attitudes of sexuality, and health related quality of life after penile surgery with small intestinal submucosa (SIS) grafting for the treatment of severe Peyronie’s disease (PD). Material and methods: This retrospective study included 82 patients, who were treated with SIS grafting for severe PD between 2009 and 2013 at the University Medical Center Hamburg-Eppendorf. Patients were asked to complete standardized questionnaires including the International Index of Erectile Function Erectile Function domain (IIEF-EF), Short-Form (SF)-8 Health Survey, and Frankfurt Body Concept Scale-Sexuality (FKKS-SEX). Results: Follow-up was available in 58 (69.9%) patients. SIS grafting resulted in subjective straightening of the penis in 53 (91.3%) patients. After a mean follow-up of 28.9 ± 16.5 months, 24 (41.4%) patients were satisfied or very satisfied with surgical outcome. Postoperatively, the mean FKKS-SEX was 23.5 ± 5.9. In total, 36 (62.1%), 18 (31%), and four (6.9%) patients had FKKS-SEX scores corresponding to positive, neutral, and negative self-perception and self-attitude of sexuality, respectively. The mean postoperative SF-8 was 15.2 ± 6.4. Compared to the mean for German controls, patients achieved lower mean scores in the domains social functioning (50.4 ± 7.1), mental health (49.5 ± 9.2), and emotional roles (48.5 ± 6.8). Subjective shortening of the penis (Odds ratio (OR): 2.0), negative body related self-perceptions, and self-attitudes of sexuality (OR: 3.6) as well as IIEF-EF score (OR: 0.9) were risk factors for patient dissatisfaction (p-values ≤ 0.02). Conclusion: A relevant number of patients is not satisfied with surgical outcome after SIS grafting for the treatment of severe PD. Subjective shortening of the penis, negative body related self-perceptions, and self-attitudes of sexuality as well as IIEF-EF score were risk factors for patient dissatisfaction.


  • Open Access

    Outcome of buccal mucosa graft urethroplasty: a detailed analysis of success, morbidity and quality of life in a contemporary patient cohort at a referral center

    by Armin Soave, Luis Kluth, Roland Dahlem, Amelie Rohwer, Michael Rink, Philipp Reiss, Margit Fisch, Oliver Engel

    To evaluate outcome of buccal mucosa graft urethroplasty (BMGU) for the treatment of urethral stricture disease, including a detailed analysis of success, morbidity and quality of life (QoL). Between 12/05/2008 and 07/21/2010, 187 patients with urethral stricture disease, who were treated with BMGU at our University Medical Center, received a standardized questionnaire, evaluating postoperative success, morbidity and QoL. The primary endpoint was the success, i.e., stricture recurrence-free survival plus patients’ satisfaction with surgery. Secondary endpoints included erectile function, voiding symptoms, pain and health-related QoL, which were assessed with a modified Urethral Stricture Surgery Patient Reported Outcome Measure (USS PROM), including the Erectile Function domain of the International Index of Erectile Function (IIEF-EF), Incontinence Questionnaire Male Lower Urinary Tract Symptoms Module (ICIQ-MLUTS) and EuroQol-5 dimensions (EQ-5D). In total, 83 patients (51.9%) completed the questionnaire. Bulbar, penile and panurethral strictures were found in 69 patients (83.1%), 13 patients (15.7%) and one patient (1.2%), respectively. The median length of the stricture was 5 cm (range: 1–16). At a median follow-up of 46 months (range: 36–54), 65 patients (78.3%) had no stricture recurrence and were satisfied with BMGU. Median scores for ICIQ-MLUTS, IIEF-EF and EQ-5D visual analogue scale were 6, 22 and 80, respectively. Based on USS PROM, postoperative improvement of QoL and satisfaction with BMGU was found in 67 patients (80.7%) and 68 patients (81.9%), respectively. In patients with urethral stricture disease, BMGU offers excellent success, morbidity and QoL.


    • 1 April 2015
      • Vol. 22  (2) , 7720-6

    Staged urethroplasty: comparison of early functional results and quality of life in mesh graft and buccal mucosa technique.

    by Daniel Pfalzgraf, Luis Kluth, Philip Reiss, Margit Fisch, Roland Dahlem

    To assess bothersome results of surgery and changes in quality of life (QoL) in patients with two-staged urethral reconstruction. In patients requiring two-staged urethroplasty a functional corpus spongiosum is usually absent, and complications such as urinary dribbling, ejaculation problems and penile deviation can be expected. Data on these complications, patient satisfaction and QoL is limited. Retrospective analysis by chart review and a standardized questionnaire of 19 consecutive patients with urethral strictures treated by two-staged urethroplasty with buccal-mucosa-graft or mesh-graft. Overall success rate was 84%. Mean follow up 11.2 months, mean length of graft 10 cm (3 cm-18 cm). Urinary stress incontinence occurred in 3 patients (16%). No penile shortening occurred in 9 (47%), no deviation in 11 (58%). Two patients (11%) reported a disturbing alteration in glans sensitivity. Regarding bother by both surgeries and the interval in between, 21% judged the first surgery as hardly or not bothersome. The time in between surgeries was hardly or not bothersome in 52% and the second surgery not or hardly bothersome in 26%. Overall satisfaction with surgery was high (79%) and an improvement in QoL was reported by 63%. Differences between the two groups did not reach statistical significance. Two-staged urethroplasty is a viable therapeutic option in patients with severe spongiofibrosis. However, specific counseling for possible complications is of utmost importance.